{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:27:26Z","timestamp":1774438046262,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/jac\/dkx059","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T03:55:12Z","timestamp":1487130912000},"page":"1812-1817","source":"Crossref","is-referenced-by-count":12,"title":["Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit"],"prefix":"10.1093","volume":"72","author":[{"given":"A. C.","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Laferri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Goyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Autmizguine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Quach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"key\n\t\t\t\t20170519062139_dkx059-B1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","year":"2002","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/660361","article-title":"Coagulase-negative staphylococcal infections in the neonatal intensive care unit","volume":"32","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1651-2227.2004.tb00708.x","article-title":"Coagulase-negative staphylococcal sepsis as a predictor of bronchopulmonary dysplasia","volume":"93","year":"2004","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B4","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/INF.0000000000000175","article-title":"The role of coagulase-negative staphylococci in early onset sepsis in a large European cohort of very low birth weight infants","volume":"33","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B5","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.2010-3338","article-title":"Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B6","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","article-title":"Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.42.1.100","article-title":"Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/520429","article-title":"Bacteremia caused by staphylococci with inducible vancomycin heteroresistance","volume":"29","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B10","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/JCM.40.7.2520-2525.2002","article-title":"Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit","volume":"40","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/JCM.01128-10","article-title":"Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method","volume":"49","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B12","first-page":"626","article-title":"Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/501605","article-title":"The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis","volume":"20","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B14","first-page":"297","article-title":"The use of daptomycin and linezolid to treat vancomycin-intermediate Staphylococcus haemolyticus infection in a premature infant","volume":"15","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/01.inf.0000225785.32137.d3","article-title":"Persistent Staphylococcus capitis septicemia in a preterm infant","volume":"25","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00228-015-1813-3","article-title":"Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants","volume":"71","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B17","first-page":"1","article-title":"Centers for Disease Control and Prevention Guidelines for the prevention of intravascular catheter-related infections","volume":"51","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0009-9236(03)00226-1","article-title":"Impact of ontogeny on linezolid disposition in neonates and infants","volume":"74","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B19","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/AAC.00177-10","article-title":"Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B20","first-page":"96","volume-title":"Antimicrobials. Neofax: A Manual of Drugs Used in Neonatal Care","year":"2010","edition":"23rd edn."},{"key":"key\n\t\t\t\t20170519062139_dkx059-B21","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkn520","article-title":"Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides","volume":"63","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B24","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1128\/AAC.00726-16","article-title":"Molecular epidemiology of a vancomycin-intermediate heteroresistant Staphylococcus epidermidis outbreak in the neonatal intensive care unit","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B25","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/01.inf.0000086955.93702.c7","article-title":"Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates","volume":"22","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B26","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/01.inf.0000087021.20838.d9","article-title":"Hematologic effects of linezolid in young children","volume":"22","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study","volume":"48","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 updateby the Infectious Diseases Society of America","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B29","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1128\/AAC.03796-14","article-title":"A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with Gram-negative bacteremia","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170519062139_dkx059-B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1368-7646(98)80029-0","article-title":"Vancomycin resistance in staphylococci","volume":"1","year":"1998","journal-title":"Drug Resist Updat"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/6\/1812\/17234942\/dkx059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T14:06:05Z","timestamp":1568815565000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,3,3]]},"published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx059","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]}}}